Welcome to PRI
Founded in 2002, PRI at Albany College of Pharmacy and Health Sciences is a center for drug discovery and development
EXPERTISE Nanotechnology, Medicinal Chemistry, Molecular Biology, Cell Biology
FOCUS Hematology/Oncology, Cardiovascular (Dyslipidemia), Ophthalmology, Vascular diseases, Neurology, Inflammation
TEACHING and LEARNING Pharmacy students, graduate students, visiting scholars from around the world visit PRI to conduct research and learn the latest advances across a wide range of therapeutic areas
Congratulations Dr Mousa !
Shaker A. Mousa elected Fellow of the National Academy of Inventors (NAI) – class of 2018! Election to NAI Fellow status is the highest professional distinction accorded to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society. The 2018 NAI Fellows class will be inducted at the Space Center Houston in April at the Eighth Annual Meeting of the NAI.
1-Day Nanomedicine Conference was held on ACPHS Campus
September 17, 2018 – View the full brochure and schedule
Dr. Paul Davis selected as Top Endocrine Pharmacologist for 2018 by the International Association of Top Professionals (IAOTP) for his outstanding leadership and commitment to the profession.
Dr. Davis is Adjunct Professor of Pharmacy at the Albany College of Pharmacy and Health Sciences and a Professor of Medicine at Albany Medical College.
CONGRATULATIONS Dr. Davis!
Dr. Mousa served as Co-chairman of the
Nanotechnology: Theory and Applications
Cairo, Egypt, December 10-13, 2018
PRI Executive Director Wins the Kuwait Prize
Congratulations Dr. Mousa !
Dr. Shaker Mousa has been named a 2017 recipient of the Kuwait Prize, one of the world’s most prestigious awards for achievements in science.
Sponsored by the Kuwait Foundation for the Advancement of Sciences (KFAS), this annual award recognizes lifetime contributions of Arab scientists across the globe. Dr. Mousa was honored in the category of Applied Sciences (Applied Medical & Applied Allied Health Sciences). The Kuwait Prize was first awarded in 1979. Award recipients are selected based on evaluations from local and international scientific institutions.
“It is my great honor to receive the Kuwait Prize for Applied Sciences, and I wish to thank the KFAS for using this awards program to stimulate interest in the scientific community and help inspire further advances,” said Dr. Mousa. “I truly believe that science knows no boundaries. The only chance we have to find better therapies for complex diseases is for the global scientific community to work together, and I value being part of that process.”
PRI Celebrates 15 Years !!
Left to Right: W. Li, K. Godugu, S.A. Mousa, P. Phillips. M. Jayaraman, D. Bharali, S. Thangirala,
M. Rajabi, B. Hay, K. Keating, O. Karakus
YT Chin, ZR He, CL Chen, …, SA Mousa, PJ Davis, et al., Frontiers in Endocrinology, 2019, 10:130
Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Colorectal cancer is a serious medical problem in Taiwan. New, effective therapeutic approaches are needed. The selection of promising anticancer drugs and the transition from pre-clinical investigations to clinical trials are often challenging. The deaminated thyroid hormone analog (tetraiodothyroacetic acid,…Read more
PJ Davis, HY Lin, AA Hercbergs, KA Keating, SA Mousa, 2019, Discovery Medicine 27:111-117
How Thyroid Hormone Works Depends on Cell Type, Receptor Type, and Hormone Analogue: Implications in Cancer Growth. The classical molecular mechanism of thyroid hormone involves the intranuclear interaction of 3,5,3′-triiodo-L-thyronine (T3) with thyroid hormone-specific nuclear proteins and consequent specific gene expression. This mechanism prevails in normal cells. What we emphasize here is that how thyroid…Read more